Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
SURMOUNT-1 Investigators
Centrally administered low-dose PRL (0.1ug/h infusion) increased hypothalamus dopamine levels, decreased serum prolactin and improved insulin secretory capacity and sensitivity
2015;308(8):F86777
For the assessment of the changes from baseline following GLP-1-based therapies in % FMD and IMT, mean differences with 95% confidence intervals (CI) were calculated between baseline samples and end-of-treatment samples for each study and then an overall effect size was generated
US$ 20.63
US$ 22.28
US$ 23.47
US$ 25.69
US$ 25.79
